More specifically, DLBCL cells express high levels of SIRT3, which deacetylates (and thus activates) GDH and other anaplerotic enzymes (like IDH2) to promote efficient entry of amino acids such as glutamine into the TCA cycle. This evidence concerns the gene IDH2 and diffuse large B-cell lymphoma.